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Objective:  To determine  trends  in  the  incidence  of  type  1 diabetes  in  Navarre  (Spain)  between  1975  and
2012  by  age  and  sex.
Patients and  methods:  The  study  population  comprised  residents  of Navarre  under 15 years  of  age. A
Poisson  regression  model  was  ﬁtted  to analyze  changes  in  the incidence  over time,  adjusted  by  year  of
diagnosis,  age  group  and  sex.
Results:  A  total  of  494  patients  were  registered,  representing  an  adjusted  incidence  rate  of  13.2/100,000
person-years.  The  annual  relative  increase  in  the  incidence  rate  was  3.7%.  The highest  incidence  was
found  in  the group  aged  10–14  years.  The  incidence  among  boys  aged  10–14  tended  to be  higher  than
that  in girls  of  the  same  age.
Conclusions:  Since  the  year 2000,  the incidence  of  type  1 diabetes  among  persons  younger  than  15 years
in  Navarre  has  been  very  high  and  has  quadrupled  over  the  last  four decades.
©  2014  SESPAS.  Published  by  Elsevier  España,  S.L.U.  All rights  reserved.
Incidencia  y  tendencia  temporal  de  la  diabetes  tipo  1  en  la  infancia,  entre  1975
y  2012,  en  Navarra  (Espan˜a)
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Objetivo:  Determinar  la  tendencia  en  la  incidencia  de  diabetes  tipo  1 en  Navarra  entre  1975 y  2012  por
edad  y  sexo.
Pacientes  y  métodos:  La  población  objeto  de  estudio  comprende  a los residentes  en Navarra  menores  de
15 an˜os  de  edad.  Para  analizar  la  evolución  de  la  incidencia  a  lo largo  del tiempo,  se  ha utilizado  un  modelo
de regresión  de  Poisson  ajustado  por an˜o  de  diagnóstico,  grupo  de  edad  y  sexo.
Resultados:  Se  han  diagnosticado  494  pacientes,  lo  que supone  una  incidencia  ajustada  de  13,2/100.000
personas-an˜o.  El  incremento  relativo  anual  en  la  tasa  de  incidencia  ha  sido  del 3,7%. El  grupo  de  edad  con
mayor  incidencia  fue  el de  10 a  14  an˜os.  En este  mismo  grupo,  la  incidencia  en  nin˜os  tiende a  ser  mayor
que  en  nin˜as.
Conclusiones:  Desde  el  an˜o  2000,  la  incidencia  de  diabetes  tipo  1 en  menores  de  15  an˜os,  en  Navarra,  es
muy  alta y  se ha  cuadriplicado  en  las  últimas  cuatro  décadas.
© 2014  SESPAS.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los  derechos  reservados.ntroduction
The incidence of type 1 diabetes (T1D) in children under
5 ranges from 0.1/100,000 person-years in Venezuela to
7.6/100,000 in Finland.1 This variation could reﬂect differences in
enetic susceptibility between populations, different exposure to
nvironmental risk factors2 or differences in features and quality
egisters.3 In Spain, the incidence is very high (20.6)1 and, between
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of the lowest.3
The highest incidence appears in the 10–14 age group, coin-
ciding with puberty.4 In some populations, however, the 5–9 age
group has the highest incidence.5 Furthermore, a shift to younger
age of onset has been described6 and, in some countries, such as
Sweden,7 Germany8 and Belgium,9 it has been debated whether
there has truly been an increase in incidence in recent years, or just
an earlier onset of the disease.Regarding the differences in incidence between the sexes before
the age of 15, it appears that in countries with a high overall inci-
dence of T1D, it is more common in boys, whereas in low-incidence
countries, it is higher among girls.10 In some registers, no difference
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Table 1
Incidence of type 1 diabetes (number of cases per 100,000, per year) by age and sex. Navarre 1975–2012.
Group age (years) Cases People/year Incidence 95% CI pa
0–4 94 1,156,439 8.1 6.5–9.7 0.607
Male  46 596,559 7.7 5.5–9.9
Female  48 559,880 8.5 6.1–11.0
5–9  148 1,225,186 12.0 10.1–14.0 0.343
Male  82 631,106 12.9 10.2–15.8
Female 66 594,080 11.1 8.4–13.8
10–14  252 1,302,921 19.3 16.7–21.7 0.051
Male  145 669,793 21.6 18.1–25.1
Female 107 633,128 16.9 13.7–20.1
<15  494 3,684,546 13.4 12.2–14.6 0.094
Male  273 1,897,458 14.3 12.7–16.1
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a Results of the test comparing incidence between males and females.
s found between the sexes9 or, where these differences appear,
hey start at the age of ten.11
In order to determine whether there has been an increase in the
ncidence and/or a change in the age of onset in Navarre, this paper
escribes the changes over the past four decades in the incidence
n children under 15 years, including characteristics in terms of age
roup and sex.
ubjects and methods
The study population comprises the residents of Navarre under
5 years of age. Information on patients diagnosed between
1/01/1975 and 31/12/1991 was obtained as described in the
rst study conducted in Navarra.12 Between 01/01/1992 and
1/12/2008; we used the same methods, using Primary Care com-
uterized information systems as main secondary source since
001. Information on patients diagnosed from 01/01/2009 to
1/12/2012 was obtained as described in our last publication.13
tatistical analysis
Incidence rates expressed per 100,000 person-years at risk
uring the study period, by age group, sex and time period
ere calculated using data from censuses and records of Navarre
Source: Spanish National Institute of Statistics). Incidence rates
ere adjusted to a standard population consisting of equal number
f children in each of six subgroups deﬁned by age group (0–4, 5–9
nd 10–14 years) and sex. Four-year time periods were considered
or calculations, except for the ﬁrst and the last one, which were
f ﬁve years. Incidence rates were adjusted to a standard popula-
ion consisting of equal number of children in each of six subgroups
eﬁned by age group (0–4, 5–9 and 10–14 years) and sex.
Conﬁdence intervals were estimated at 95%, assuming an
nderlying Poisson distribution. A Chi-square test was used to
ompare incidence between groups (independence test), A Poisson
able 2
rude and adjusted incidence rate of type 1 diabetes (number of cases per 100,000 perso
Period Cases People/year 
Rat
1975–1979 29 630,456 4.6
1980–1983  48 483,523 9.9
1984–1987  45 441,642 10.1
1988–1991  61 384,287 15.8
1992–1995 48 333,886 14.3
1996–1999  36 304,741 11.8
2000–2003  63 305,547 20.6
2004–2007  70 334,443 20.9
2008–2012  94 466,021 20.1
ote: 1975–1979 and 2008–2012 span ﬁve years while the remaining periods span four y12.3 10.7–14.0
regression model was used to analyze changes in incidence since
1975, adjusted for year of diagnosis, age group and sex, from which
rate ratios were obtained, together with their 95% conﬁdence inter-
vals. Interaction terms were also included to assess whether time
trend differed among age groups or sex, and removed if not sig-
niﬁcant. For statistical analysis, IBM SPSS Statistics 20 and R 2.13.1
were used.
This study has been reviewed and approved by the Navarre
Research Ethics Committee.
Results
A total of 494 new cases of T1D aged under 15 (273 boys and 221
girls) were recorded, equivalent to a crude incidence rate of 13.4 per
100,000 inhabitants per year (95% CI: 12.2–14.6) and an adjusted
incidence rate of 13.2 (95% CI: 12.0–14.3) (Table 1). The age group
with the highest incidence was  the 10–14 year-olds (p < 0.001). The
incidence in boys, 14.3 (95% CI: 12.7–16.1), was higher than in girls,
12.3 (95% CI: 10.7–14.0), but no signiﬁcant differences (p = 0.094)
were observed except the trend in the 10–14 age group, for which
the statistical signiﬁcance was  marginal (p = 0.051) (Table 1).
Adjusted incidences for four or ﬁve-year periods are shown in
Table 2. The highest incidence was recorded in 2004–2007 (21.1;
95% CI: 16.2–26.1) and the lowest, between 1975 and 1979 (4.6;
95% CI: 2.9–6.2) (Table 2). The overall rate of diagnosis increases
markedly up to the period 2000–2003, before stabilizing between
20 and 21 cases per 100,000 until the end of the study period.
The results of the Poisson regression model show an annual
relative increase of 3.7% (95% CI: 2.9–4.5%) in the incidence rate
(p < 0.001). Compared to the group under 5 years, the incidence
rate in children aged 5–9 is 1.53 (95% CI: 1.18–1.99), and that of
children aged 10–14 is 2.50 (95% CI: 1.98–3.18). The rate ratio for
boys versus girls is 1.16 (95% CI: 0.97–1.39). We did not ﬁnd the
time trend to be different between age groups (interaction term
p-value = 0.912) or sex (interaction term p-value = 0.745).
n-years) by time period. Navarre 1975–2012.
Crude incidence Adjusted incidence
e 95% CI Rate 95% CI
 2.9–6.3 4.6 2.9–6.2
 7.1–12.7 9.8 7.0–12.6
 7.2–13.2 9.9 7.0–12.8
 11.9–19.9 14.4 10.8–17.9
 10.3–18.4 14.0 10.0–18.0
 7.9–15.7 11.4 7.7–15.2
 15.5–25.7 20.8 15.6–25.9
 16.0–25.8 21.1 16.2–26.1
 16.1–24.2 20.7 16.5–24.9
ears.
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What is known about the topic?
Most of National Diabetes Registries agree that the inci-
dence of type 1 diabetes in children is increasing. But, on the
other hand, a shift to younger age of onset has been described.
So, its being debated whether there is truly an increase in
incidence or just an earlier onset of the disease.
What this study adds to the literature?
In this study we show that the incidence of type 1 diabetes in
children, in Navarre, has quadrupled over the last four decades.
The age group with the highest incidence has not changed.
So, the public health systems should be aware of this increase
in order to prepare the necessary resources to confront this
important health problem and prevent its personal and socialL. Forga Llenas et al. / G
iscussion
The incidence of T1D in children in Navarre increased over time,
rom 1975 to 2012, in the three age groups studied. The age group
ith the highest incidence was 10–14 years among all the study
eriod, with an incidence rate over these years of more than twice
hat of children under ﬁve.
The strength of this study lies in its incidence data record of
8 years, a longer period than can be found in most published
apers. In addition, the methods for collecting patients have been
omprehensive from the start. Limitations include the fact that,
or the size of the population of Navarre, the annual rates are not
table, showing large relative changes in magnitude. Moreover,
here is always the possibility that the method has not succeeded
n recording 100% of patients. Such an underestimation would be
ore likely in the early years of the study. However, even the data
rom the initial period, which is less complete (94.6%), is complete
nough to be reliable and be included in the incidence study.
The increase is not linear, but does not suggest any cyclical
attern as described by other authors.6 The annual relative mean
ncrease in the incidence rate is 3.7%, which is very close to the
verage for the EURODIAB data.4 although in our case, rates did
ot increase in the ﬁnal decade of the study period, in line with
he reported data from Oxford (UK), which are included in the
URODIAB group.
Some authors7–9 have questioned the increased incidence the-
ry, suggesting that the data simply reveal an earlier age of onset.
he present study reports increased incidence in all three age
roups. Therefore, although it cannot be ruled out that there has
een a shift in the age of diagnosis to childhood at the expense
f adult patients, the authors are inclined to think that there has
n fact been a real increase in the incidence of T1D and not a mere
hift. This opinion is in line with Harjutsalo et al. in Finland.11 More-
ver, in 2011, the same Swedish group that questioned the increase
n incidence,7 published a paper again reporting that, since 2000,
he age group with the highest incidence in children is the 10–14
ear-olds.14
The incidence among boys tends to be higher than among girls
n the 10–14 age group. This trend is consistent with results pub-
ished from some European countries,11 It has been suggested that
hysiological changes due to puberty act as triggers for diabetes,13
hich could explain the increased incidence in boys aged 10–14,
ince they reach puberty later than girls. However, in contrast to
ndings from other groups,15 no peak in incidence was observed
n girls in the 5–9 age group. On the contrary, the incidence is still
ower than in boys, suggesting that the difference in the timing of
he onset of puberty does not explain the higher incidence observed
n males aged 10–14.
In conclusion, the incidence of T1D in children under 15 in
avarre has quadrupled in the last four decades, with an annual rel-
tive increase in the incidence rate similar to that of neighbouring
ountries.
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